Betta Pharmaceuticals
589 Hongfeng Road
Yuhang Economic and Technological Development Area
Hangzhou
China
Tel: 0571-86130357
Website: http://en.bettapharma.com/
About Betta Pharmaceuticals
Betta Pharmaceuticals Co., Ltd. is a national-level high-tech pharmaceutical company founded by a team of PhD returnees. Betta Pharmaceuticals has established an integrated organization of research and development, manufacturing, sales and marketing with emphasis R&D of innovative drugs and proprietary intellectual property rights. Ever since its establishment in 2003, it has fully committed to R&D and manufacturing of first class national innovative drugs with proprietary intellectual property rights directed at diseases with significant impacts on human health such as malignant tumors, diabetes, cardiovascular and cerebrovascular diseases and so forth.YEAR FOUNDED:
2003
LEADERSHIP:
CEO: Ding Lieming
CSO: Wang Yinxiang
CMO: Tan Fenlai
JOBS:
Please click here for Betta Pharmaceuticals job opportunitites.
PRODUCTS:
All Products
5 articles about Betta Pharmaceuticals
-
EyePoint Pharmaceuticals Announces Expanded License Agreement with Betta Pharmaceuticals for EYP-1901 in China, Hong Kong, Macau and Taiwan
5/4/2022
EyePoint Pharmaceuticals, Inc. today announced the execution of a license agreement with Betta Pharmaceuticals Co. Ltd. (SHE: 300558) to develop and commercialize EYP-1901 in Mainland China, Hong Kong, Macau and Taiwan.
-
Agenus and Betta Pharmaceuticals Enter Into a License Agreement for Balstilimab and Zalifrelimab in Greater China
6/22/2020
Agenus Inc. announced that it has entered into an agreement with Betta Pharmaceuticals, a top Chinese pharmaceutical company focusing on the development of innovative oncology therapies, for an exclusive collaboration and license agreement for the development and commercialization of balstilimab and zalifrelimab in Greater China, including Mainland China, Hong Kong, Macau and Taiwan.
-
ProBioGen's GlymaxX® ADCC Enhancement Technology Used by Betta Pharmaceuticals
1/3/2019
Bispecific Antibody for Cancer Treatment Optimized by GlymaxX® Technology
-
NuProbe Forms Scientific Advisory Board and Appoints New Director
7/24/2018
NuProbe Global announced today the formation of its Scientific Advisory Board (SAB) with genomics pioneers George M. Church, Ph.D. and David R. Walt, Ph.D.
-
Betta Pharmaceuticals Completes $106 Million IPO In Shenzhen
11/8/2016